Home » Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work

Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work

November 5, 2026November 5, 2026

Business drug discovery is a needle in a haystack problem this ai startup thinks it has the answer v1

This post was originally published on this site.

Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs.

FlashNews:

SMUD Rebates Up to $3,000 for Heat Pumps and Heating Systems Before Winter

GoodsQC Introduces Structured Product Sourcing Workflow to Support Overseas Buyers Shopping on Chinese Marketplaces

Wyndham Unveils Asia Pacific New Year Offers

No great shakes: the quest for palatable high-protein drinks

Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work

Motorola Wants to Sell You a $1,600 Phone That Doesn’t Fold

Fashion Label Guizio Launches Perfume

Tapestry Lifts Outlook as Young Shoppers Snap Up Coach Bags

Trump’s memecoin ventures derailed CLARITY Act, Scaramucci says

European stocks approach all-time high on Democratic sweep

Married at First Sight UK cancelled after BBC revealed rape allegations

Stone to be laid for Mobo founder Kanya King

VIVA Cruises announces new name for Douro ship

Thailand to block Bitget in December over unlicensed crypto trading

Air India hosts UK travel trade leaders in London with Hon’ble Minister of Tourism and Culture

Wall Street bets Democratic sweep will empower moderates in Washington

You will die. That’s why your life is worth living

2026 HUAI’AN GOLDEN AUTUMN ECONOMIC AND TRADE SYMPOSIUM OPENS

Camtep Prepares for UK Industry Exhibition as Cross-Border Collaboration Platform Development Continues

Line Avenue Introduces Privileged Access Program for Its Banking and Trading Platform

Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work